http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011048077-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26d8b02bc04211e4bc4f679cd6b119e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efb915ca02e2c32a4e41b9207d3756dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7d909386a518ac828829b6dfc8bdb67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b713b94472f473ffa14dfdc3ca831dca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23aa279a8046e63d1bbce0c212a60b61
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-414
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-412
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-8033
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-26
filingDate 2010-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25341554858a73482706ecbd64b756ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59de3021b08530aeae01769c6e066e6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d98c5a2b328d69c32510896535b7a99c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f12239f8e7739d3f4b9bb8b95fcbc380
publicationDate 2011-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2011048077-A3
titleOfInvention Composition for the treatment of a bone fracture
abstract There is disclosed a composition formed by a reaction of at least one component A and at least one component B, wherein component A is selected from the group consisting of a compound comprising at least two thiol-groups and a disulfide derivative of a compound comprising at least two thiol groups, and wherein component B is a compound comprising at least two vinyl groups, for the manufacture of an implant for the treatment of a bone fracture. Advantages include that the adhesive patch formed by the composition will be solid in body fluid upon curing and will exhibit excellent mechanical strength. Advantages include that the composition is biocompatible, the material can be applied in small and inaccessible areas, the process requires less surgeon training, it solves drawback with open surgery, and it is possible to use cost effective materials and methods in the process.
priorityDate 2009-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009058079-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005086911-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03011926-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397808

Total number of triples: 32.